Literature DB >> 33507751

Hybrid QconCAT-Based Targeted Absolute and Data-Independent Acquisition-Based Label-Free Quantification Enables In-Depth Proteomic Characterization of Wheat Amylase/Trypsin Inhibitor Extracts.

Malte Sielaff1, Valentina Curella2, Manjusha Neerukonda2, Muhammad Afzal3, Khaoula El Hassouni3, Ute Distler1, Detlef Schuppan2,4, C Friedrich H Longin3, Stefan Tenzer1.   

Abstract

Wheat amylase/trypsin inhibitors (ATIs) have gained significant relevance as inducers of intestinal and extra-intestinal inflammation. In this study, we present a novel hybrid data-independent acquisition (DIA) liquid chromatography-mass spectrometry (LC-MS) approach, combining QconCAT technology with short microflow LC gradients and DIA and apply the method toward the quantitative proteome analysis of ATI extracts. The presented method is fast, robust, and reproducible and provides precise QconCAT-based absolute quantification of major ATI proteins while simultaneously quantifying the proteome by label-free quantification (LFQ). We analyzed extracts of 60 varieties of common wheat grown in replication and evaluated the reproducibility and precision of the workflow for the quantification of ATIs. Applying the method to analyze different wheat species (i.e., common wheat, spelt, durum wheat, emmer, and einkorn) and comparing the results to published data, we validated inter-laboratory and cross-methodology reproducibility of ATI quantification, which is essential in the context of large-scale breeding projects. Additionally, we applied our workflow to assess environmental effects on ATI expression, analyzing ATI content and proteome of same varieties grown at different locations. Finally, we explored the potential of combining QconCAT-based absolute quantification with DIA-based LFQ proteome analysis for the generation of new hypotheses or assay development.

Entities:  

Keywords:  QconCAT; Triticum aestivum; alpha-amylase/trypsin inhibitor; bottom-up proteomics; celiac disease; data-independent acquisition; flour; label-free quantification; non-celiac wheat sensitivity; wheat

Year:  2021        PMID: 33507751     DOI: 10.1021/acs.jproteome.0c00752

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  3 in total

Review 1.  Wheat amylase/trypsin inhibitors (ATIs): occurrence, function and health aspects.

Authors:  Sabrina Geisslitz; Peter Weegels; Peter Shewry; Victor Zevallos; Stefania Masci; Mark Sorrells; Armando Gregorini; Mariastella Colomba; Daisy Jonkers; Xin Huang; Roberto De Giorgio; Giacomo P Caio; Stefano D'Amico; Colette Larré; Fred Brouns
Journal:  Eur J Nutr       Date:  2022-03-02       Impact factor: 4.865

2.  Absolute and relative quantitation of amylase/trypsin-inhibitors by LC-MS/MS from wheat lines obtained by CRISPR-Cas9 and RNAi.

Authors:  Sabrina Geisslitz; Shahidul Islam; Lukas Buck; Clemens Grunwald-Gruber; Francesco Sestili; Francesco Camerlengo; Stefania Masci; Stefano D'Amico
Journal:  Front Plant Sci       Date:  2022-08-29       Impact factor: 6.627

3.  Genetic architecture underlying the expression of eight α-amylase trypsin inhibitors.

Authors:  Khaoula El Hassouni; Malte Sielaff; Valentina Curella; Manjusha Neerukonda; Willmar Leiser; Tobias Würschum; Detlef Schuppan; Stefan Tenzer; C Friedrich H Longin
Journal:  Theor Appl Genet       Date:  2021-07-10       Impact factor: 5.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.